Found: 3
Select item for more details and to access through your institution.
Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40022-5
- By:
- Publication type:
- Article
HORMAD1 overexpression predicts response to anthracycline–cyclophosphamide and survival in triple‐negative breast cancers.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 10, p. 2017, doi. 10.1002/1878-0261.13412
- By:
- Publication type:
- Article
Acetyl-CoA carboxylase 1 controls a lipid droplet–peroxisome axis and is a vulnerability of endocrine-resistant ER<sup>+</sup> breast cancer.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 736, p. 1, doi. 10.1126/scitranslmed.adf9874
- By:
- Publication type:
- Article